TEMPUS AI
LIVE

Serial Number

98087704

Owner

TEMPUS AI, INC.

Attorney

Jeremy D. Bisdorf

Filing Date

Jul 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TEMPUS AI Trademark

Serial Number: 98087704

TEMPUS AI is a trademark filed by TEMPUS AI, INC. on July 17, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

TEMPUS AI, INC. (73 trademarks)

600 W. CHICAGO AVE.
CHICAGO, IL 60654

Entity Type: 03

Tempus Labs, Inc. (47 trademarks)

600 WEST CHICAGO AVENUE, SUITE 510
CHICAGO, IL 60654

Entity Type: 03

Trademark Details

Filing Date

July 17, 2023

Registration Date

Not Registered

Published for Opposition

February 27, 2024

Goods & Services

Downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology, electrophysiology, oncology, neurology, and mental health; downloadable and recorded computer software using artificial intelligence for machine learning for supporting clinical data platforms for cardiac diagnostics and electrophysiology

Medical services; genetic and health information analysis and diagnostics for medical purposes; providing an Internet website portal featuring patient health information in the fields of oncology, electrophysiology, cardiology, neurology, and mental health; medical services in the fields of cardiology, electrophysiology, oncology, neurology, and mental health diagnostics and testing; providing medical diagnostic testing that analyzes patient samples and creates genomic data from the analysis

Platform as a service (PAAS) featuring computer software platforms for medical access to patient health information; Providing a web site featuring technology that enables users to access patient health information; Software as a service (SAAS) services featuring software for medical access to patient health information; Platform as a service (PaaS) featuring computer software platforms for voice command and recognition software, speech to text conversion software, and voice-enabled software applications for information management in the field of electronic health records relating to oncology, cardiology, neurology, and mental health; Providing temporary use of online non-downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Medical research; Medical and scientific research in the fields of genomics, genomic sequencing and genomic analysis; Software as a Service (SaaS) services featuring software for the review and analysis of medical images in the fields of radiology and pathology that provides actionable insights to add clinical value, improve diagnostic decision making, efficiency, and productivity, in the fields of oncology, cardiology, neurology, and mental health; medical and scientific research in the fields of diabetes, cardiology, neurology, oncology, electrophysiology, and mental health; providing medical and scientific research information in the fields of diabetes, cardiology, neurology, oncology, electrophysiology, and mental health; medical and scientific research and development services in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; computer system design and analysis for use in cardiology, neurology, oncology, electrophysiology, and mental health; software development for cardiac diagnostics and cardiology and electrophysiology; platform as a service (PAAS) services featuring computer software platforms for operating cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring software for cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; platform as a service (PAAS) services featuring computer software platforms employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; providing a website featuring on-line non-downloadable software that enables users to analyze genome sequences for disease assessment, prediction of medical and clinical outcomes, medical and clinical research, and drug development; providing a website featuring on-line non-downloadable software that enables users to collect, organize, and store genetic and genomic information of medical patients for diagnosis and treatment assistance; database development services, namely, curating, managing and organizing data libraries of genomic and medical information for healthcare professionals in cloud computing application systems; software as a service (SAAS) services featuring software for genomic sequencing, genomic related data analysis, and data management for hospitals and research centers; clinical research in the field of genomics; Structural and functional analysis of genomes; computer system design for use in oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; platform as a service (PAAS) services featuring computer software platforms for operating clinical decision support in the fields of diabetes, neurology, and mental health diagnostics and testing; software as a service (SAAS) services featuring software for clinical decision support in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; platform as a service (PAAS) featuring computer software platforms for clinical decision support in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2026 EXRA
SOU EXTENSION 4 GRANTED
Apr 3, 2026 EX4G
SOU EXTENSION 4 FILED
Apr 3, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 8, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 30, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 30, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 16, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 20, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 20, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 20, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 20, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 23, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 23, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 23, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 23, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2024 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 17, 2024 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 28, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 28, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 28, 2023 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2023 NWOS
NEW APPLICATION ENTERED
Jul 20, 2023 NWAP